Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Miris Holding

38.70 SEK

Less than 1K followers

MIR

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Miris Holding

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue4.65.017.64.65.04.93.017.5
EBITDA-0.7-0.2-4.8-1.7-0.7-0.4-1.3-4.0
EBIT-0.7-0.2-5.3-1.7-0.7-0.4-1.3-4.0
EBIT-%-14.6 %-4.8 %-30.1 %-36.2 %-13.7 %-7.3 %-43.1 %-22.8 %
Profit before taxes-0.9-0.5-6.3-1.9-1.0-0.6-1.4-4.8
Net income-0.9-0.5-6.3-1.9-1.0-0.6-1.4-4.8
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.